Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PROGENICS PHARMACEUTICALS IN Analyst Recommendations

  • Analyst Consensus: PGNX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.600 Hold 5
    30 Days Ago 2.800 Hold 5
    60 Days Ago 2.667 Hold 6
    90 Days Ago 2.667 Hold 6
    120 Days Ago 2.667 Hold 6

  • Analyst Ratings: PGNX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Needham Buy Hold 10/14/2009 —
    RBC Capital Mkts — Outperform 05/12/2009 12.00
    RBC Capital Mkts — Outperform 03/16/2009 14.00
    Brean Murray Buy Hold 03/16/2009 —
    Oppenheimer Outperform Perform 03/16/2009 —
    FTN Equity Capital — Neutral 03/12/2009 —
    RBC Capital Mkts — Outperform 08/11/2008 21.00
    Friedman Billings Underperform — 07/10/2008 —
    Friedman Billings Mkt Perform Underperform 07/02/2008 12.00
    Ladenburg Thalmann — Buy 06/06/2008 40.00
    Brean Murray — Buy 05/22/2008 20.00
    Citigroup Sell Hold 04/25/2008 —
    Friedman Billings — Mkt Perform 04/25/2008 9.00
    RBC Capital Mkts — Outperform 03/13/2008 10.00
    Punk, Ziegel & Co — Buy 03/12/2008 15.00
    Friedman Billings Outperform Mkt Perform 03/12/2008 8.00
    Brean Murray — Buy 03/12/2008 15.00
    Lazard Capital Buy Hold 03/12/2008 —
    Lazard Capital — Buy 01/10/2008 32.00
    Broadpoint Capital — Buy 11/08/2007 30.00
    Lazard Capital — Buy 05/01/2007 37.00
    Punk, Ziegel & Co — Buy 04/02/2007 38.00
    Lazard Capital — Buy 03/07/2007 32.00
    Punk, Ziegel & Co — Buy 03/07/2007 38.00
    CIBC Wrld Mkts — Sector Outperform 03/07/2007 31.00
    Friedman Billings — Outperform 03/07/2007 35.00
    Friedman Billings — Outperform 02/14/2007 38.00
    RBC Capital Mkts Sector Perform Outperform 01/29/2007 35.00
    First Albany — Buy 12/22/2006 33.00
    Am Tech/JSA Research — Buy 11/06/2006 36.00
    Next